Burning Rock Biotech Ltd ADR (BNR) Stock Price, Quote & News

Company Profile

Burning Rock Biotech Limited develops and sells cancer therapy selection tests in the People's Republic of China and the United States. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company offers next-generation sequencing (NGS)-based tissue, liquid biopsy cancer therapy selection, and prognosis prediction tests for various cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast c...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 86 20 3403 7871

Website: www.brbiotech.com

Address:

No. 5, Xingdao Ring Road North, International Bio Island, Guangzhou, China

OfficialStocktwitsUser Feb. 27 at 9:37 PM

$BNR RSI: 26.28, MACD: -0.9541 Vol: 3.61, MA20: 30.17, MA50: 27.69 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

BillionerOfKing Feb. 22 at 1:50 PM

$BNR Current Stock Price: $29.00

0 · Reply

DeltaWalker Feb. 18 at 10:23 AM

$BNR China clean energy exposure with policy dependency.

0 · Reply

RHoney Feb. 4 at 1:43 PM

$BNR escalating levels of support.

1 · Reply

BillionerOfKing Jan. 28 at 3:13 PM

$BNR Current Stock Price: $35.97

0 · Reply

RHoney Jan. 25 at 12:46 PM

$BNR lots of upside potential , this uptick has a long way to go

0 · Reply

DataCenterTrader Jan. 22 at 7:26 PM

Watch SVRE next SMX Defense innovation + RF tech + ultra-low float + technical gap potential = a cocktail that attracts momentum traders fast. doesn’t need perfection it just needs attention and volume to reprice aggressively. $GLD $USO $BNR $SMX …

0 · Reply

isaacwilliams33 Jan. 13 at 6:44 PM

$BNR was doing good last yime I checked

0 · Reply

DeepLearningD3 Dec. 26 at 4:10 PM

$BNR Expectations are recalibrating toward pragmatic delivery instead of lofty projections. Cash efficiency must trend upward while maintaining strategic flexibility. Clear execution would attract broader institutional participation. Durable value creation requires execution to catch up with vision.

1 · Reply

FinTechFighter Dec. 24 at 12:37 PM

$BNR Sentiment could pivot sharply depending on how measurable traction replaces episodic catalyst-driven interest. Execution slippage remains the dominant downside risk.

0 · Reply

Burning Rock's OncoGuide™ OncoScreen™ Plus CDx System Now Approved in Japan as a Companion Diagnostic for Capivasertib in Breast Cancer

Burning Rock Reports Second Quarter 2025 Financial Results

Sep 8, 2025, 1:39 AM EDT - 6 months ago

Burning Rock's minimal residual disease (MRD) product supports advancement in early-stage non-small cell lung cancer treatment, with results published in the Cancer Cell

Burning Rock Biotech Limited (BNR) Q2 2023 Earnings Call Transcript

Aug 31, 2023, 3:12 PM EDT - 2 years ago

Burning Rock's precision oncology diagnostics product supports advancement in late-stage breast cancer treatment, with results published in the New England Journal of Medicine

Burning Rock Biotech Limited (BNR) Q1 2023 Earnings Call Transcript

May 30, 2023, 10:25 AM EDT - 2 years ago

BillionerOfKing Feb. 22 at 1:50 PM

$BNR Current Stock Price: $29.00

0 · Reply

DeltaWalker Feb. 18 at 10:23 AM

$BNR China clean energy exposure with policy dependency.

0 · Reply

RHoney Feb. 4 at 1:43 PM

$BNR escalating levels of support.

1 · Reply

BillionerOfKing Jan. 28 at 3:13 PM

$BNR Current Stock Price: $35.97

0 · Reply

RHoney Jan. 25 at 12:46 PM

$BNR lots of upside potential , this uptick has a long way to go

0 · Reply

DataCenterTrader Jan. 22 at 7:26 PM

0 · Reply

isaacwilliams33 Jan. 13 at 6:44 PM

$BNR was doing good last yime I checked

0 · Reply

DeepLearningD3 Dec. 26 at 4:10 PM

1 · Reply

FinTechFighter Dec. 24 at 12:37 PM

$BNR Sentiment could pivot sharply depending on how measurable traction replaces episodic catalyst-driven interest. Execution slippage remains the dominant downside risk.

0 · Reply